ATS GUIDELINES Bundle

Acute Respiratory Failure

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: http://eguideline.guidelinecentral.com/i/1101457

Contents of this Issue

Navigation

Page 2 of 5

Cardiogenic Pulmonary Edema ➤ We recommend either bilevel NIV or CPAP for patients with ARF due to cardiogenic pulmonary edema. (strong recommendation, moderate certainty of evidence) ➤ We suggest that CPAP or bilevel NIV be used for patients with ARF due to cardiogenic pulmonary edema in the pre-hospital setting. (conditional recommendation, low certainty of evidence) Acute Asthma ➤ Given the uncertainty of evidence we are unable to offer a recommendation on the use of NIV for ARF due to asthma. Immunocompromise ➤ We suggest early NIV for immunocompromised patients with ARF. (conditional recommendation, moderate certainty of evidence) De Novo ARF ➤ Given the uncertainty of evidence we are unable to offer a recommendation on the use of NIV for de novo ARF. Post-Op ➤ We suggest NIV for patients with post-operative ARF. (conditional recommendation, moderate certainty of evidence) Palliative Care ➤ We suggest offering NIV to dyspneic patients for palliation in the setting of terminal cancer or other terminal conditions. (conditional recommendation, moderate certainty of evidence) Treatment

Articles in this issue

view archives of ATS GUIDELINES Bundle - Acute Respiratory Failure